InsiderTrades.com logo

CERO Insider Trading

Insider Ownership Percentage: 12.72%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $529,060.00

CERo Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at CERo Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CERo Therapeutics Share Price & Price History

Current Price: $0.11
Price Change: ▲ Price Increase of +0.0287 (34.50%)
As of 12/4/2025 04:59 PM ET

This chart shows the closing price history over time for CERO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

CERo Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/13/2024Bioventures Opportunities G YkMajor ShareholderSell1,499$120.00$179,880.006,502View SEC Filing Icon  
12/11/2024Bioventures Opportunities G YkMajor ShareholderSell671$160.00$107,360.008,809View SEC Filing Icon  
12/9/2024Bioventures Opportunities G YkMajor ShareholderSell425$220.00$93,500.0010,266View SEC Filing Icon  
12/6/2024Bioventures Opportunities G YkMajor ShareholderSell618$240.00$148,320.0010,691View SEC Filing Icon  
10/10/2024Bioventures Opportunities G YkMajor ShareholderSell1,625$200.00$325,000.0011,310View SEC Filing Icon  
9/25/2024Stuart M SloanMajor ShareholderSell266$200.00$53,200.0010,533View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for CERo Therapeutics (NASDAQ:CERO)

29.64% of CERo Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CERO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CERo Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/15/2025Armistice Capital LLC312,000$0.23M0.0%N/A5.798%Search for SEC Filing on Google Icon
4/29/2025Avantax Planning Partners Inc.74,321$54K0.0%-97.1%2.453%Search for SEC Filing on Google Icon
4/8/2025Parallel Advisors LLC220,000$0.16M0.0%N/A7.261%Search for SEC Filing on Google Icon
2/17/2025ARCH Venture Management LLC9,393,561$0.56M0.2%+550.4%626.237%Search for SEC Filing on Google Icon
2/7/2025Avantax Planning Partners Inc.2,585,151$0.16M0.0%+89.9%171.999%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CERo Therapeutics logo
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Read More on CERo Therapeutics

Today's Range

Now: $0.11
Low: $0.08
High: $0.14

50 Day Range

MA: $1.74
Low: $0.06
High: $5.46

52 Week Range

Now: $0.11
Low: $0.05
High: $412.00

Volume

813,681 shs

Average Volume

1,045,099 shs

Market Capitalization

$134.84 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of CERo Therapeutics?

CERo Therapeutics' top insider investors include:
  1. Bioventures Opportunities G Yk (Major Shareholder)
  2. Stuart M Sloan (Major Shareholder)
Learn More about top insider investors at CERo Therapeutics.